Application of PLGA Nanoparticles in Cancer Therapy
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 627
Special Issue Editor
Interests: nanotechnology; pH-responsive drug delivery system; in vitro methods; cell culture; antitumor activity; drug targeting; drug quality control; liquid chromatography; toxicology
Special Issue Information
Dear Colleagues,
Pharmaceutics is excited to present a Special Issue focused on the “Application of PLGA Nanoparticles in Cancer Therapy”.
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles are at the forefront of cancer treatment innovations due to their biocompatibility, biodegradability, and ability to encapsulate a wide range of therapeutic agents. These nanoparticles enhance the targeted delivery and controlled release of anticancer drugs, reducing side effects and improving treatment efficacy. The scientific background highlights PLGA's versatility in overcoming biological barriers and enhancing drug solubility. This Special Issue aims to explore the latest advancements in PLGA nanoparticle research, focusing on formulation strategies, targeting mechanisms, and clinical applications. Researchers are invited to contribute studies on novel PLGA-based therapies, characterization techniques, and the integration of imaging for theranostic applications. By gathering cutting-edge research, this Special Issue seeks to provide a comprehensive overview of the potential and future directions of PLGA nanoparticles in cancer therapy.
In this Special Issue, original research articles and reviews are welcome to be submitted. We look forward to receiving your contributions.
Dr. Daniele Rubert Nogueira-Librelotto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- PLGA nanoparticles
- cancer therapy
- drug delivery
- biocompatibility
- controlled release
- targeted therapy
- theranostics
- formulation strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
